Abstract
Optical coherence tomography (OCT) has transformed the understanding of the anatomy of the vitreomacular interface (VMI) and pathologic processes that occur there. Since the first description of macular diseases with OCT in 1995, progressive advances in technology have made OCT the gold standard for the diagnosis and management of VMI diseases (Puliafito et al. 1995; Stalmans et al. 2013). Clinical biomicroscopic examination and other imaging modalities are limited in their capabilities to fully diagnose and document diseases of the VMI as vitreous membranes are often clinically invisible. Spectral domain OCT (SD-OCT) provides high-resolution images of the VMI with noninvasive capture and fast acquisition. SD-OCT enables the clinician to more accurately diagnose diseases of the VMI, informs treatment, and guides postoperative care (Folgar et al. 2012). The approval of ocriplasmin (Jetrea, ThromboGenics, Iselin, New Jersey) for pharmacologic vitreolysis of “symptomatic vitreomacular adhesion” has further stimulated interest in understanding the pathophysiology of the VMI (FDA 2012). These developments led to the formation of the International Vitreomacular Traction Study (IVTS) Group to create a strictly anatomic OCT-based classification system for the VMI and more specifically the vitreomacular interface (VMI) (Duker et al. 2013). The panel of vitreoretinal disease experts provided anatomic definitions and classification of vitreomacular adhesion (VMA), vitreomacular traction (VMT), and full-thickness macular hole (FTMH). This classification system and the science upon which it is based inform the current diagnosis and management of diseases of the VMI.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bishop PN (2000) Structural macromolecules and supramolecular organisation of the vitreous gel. Prog Retin Eye Res 19:323–344
Chang S, Gregory-Roberts EM, Park S, Laud K, Smith SD, Hoang QV (2013) Double peeling during vitrectomy for macular pucker: the Charles L. Schepens Lecture. JAMA ophthalmol 131:525–530. doi:10.1001/jamaophthalmol.2013.2176
Chen W, Mo W, Sun K, Huang X, Zhang YL, Song HY (2009) Microplasmin degrades fibronectin and laminin at vitreoretinal interface and outer retina during enzymatic vitrectomy. Curr Eye Res 34:1057–1064. doi:10.3109/02713680903308487
de Faria JM L, Jalkh AE, Trempe CL, McMeel JW (1999) Diabetic macular edema: risk factors and concomitants. ActaophthalmologicaScandinavica 77:170–175
DeCroos FC, Toth CA, Folgar FA, Pakola S, Stinnett SS, Heydary CS, Burns R, Jaffe GJ (2012) Characterization of vitreoretinal interface disorders using OCT in the interventional phase 3 trials of ocriplasmin. Invest Ophthalmol Vis Sci 53:6504–6511. doi:10.1167/iovs.12-10370
Do DV, Cho M, Nguyen QD, Shah SM, Handa JT, Campochiaro PA, Zimmer-Galler I, Sung JU, Haller JA (2006) The impact of optical coherence tomography on surgical decision making in epiretinal membrane and vitreomacular traction. Trans Am Ophthalmol Soc 104:161–166
Duker JS, Kaiser PK, Binder S, de Smet MD, Gaudric A, Reichel E, Sadda SR, Sebag J, Spaide RF, Stalmans P (2013) The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology 120:2611–2619. doi:10.1016/j.ophtha.2013.07.042
Fahim AT, Khan NW, Johnson MW (2014) Acute panretinal structural and functional abnormalities after intravitreous ocriplasmin injection. JAMA ophthalmol 132:484–486. doi:10.1001/jamaophthalmol.2013.8142
Falkner-Radler CI, Glittenberg C, Hagen S, Benesch T, Binder S (2010) Spectral-domain optical coherence tomography for monitoring epiretinal membrane surgery. Ophthalmology 117:798–805. doi:10.1016/j.ophtha.2009.08.034
FDA U (2012) FDA approves Jetrea for symptomatic vitreomacular adhesion in the eyes [press release]. Updated 18 Oct 2012. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm324369.htm. Accessed 1 June 2014
Folgar FA, Toth CA, DeCroos FC, Girach A, Pakola S, Jaffe GJ (2012) Assessment of retinal morphology with spectral and time domain OCT in the phase III trials of enzymatic vitreolysis. Invest Ophthalmol Vis Sci 53:7395–7401. doi:10.1167/iovs.12-10379
Freund KB, Shah SA, Shah VP (2013) Correlation of transient vision loss with outer retinal disruption following intravitreal ocriplasmin. Eye 27:773–774. doi:10.1038/eye.2013.94
Gandorfer A, Rohleder M, Kampik A (2002) Epiretinal pathology of vitreomacular traction syndrome. Br J Ophthalmol 86:902–909
Gaudric A, Haouchine B, Massin P, Paques M, Blain P, Erginay A (1999) Macular hole formation: new data provided by optical coherence tomography. Arch Ophthalmol 117:744–751
Goldberg RA, Waheed NK, Duker JS (2014) Optical coherence tomography in the preoperative and postoperative management of macular hole and epiretinal membrane. Br J Ophthalmol 98:ii20–3. doi:10.1136/bjophthalmol-2013-304447
Haouchine B, Massin P, Gaudric A (2001) Foveal pseudocyst as the first step in macular hole formation: a prospective study by optical coherence tomography. Ophthalmology 108:15–22
Haouchine B, Massin P, Tadayoni R, Erginay A, Gaudric A (2004) Diagnosis of macular pseudoholes and lamellar macular holes by optical coherence tomography. Am J Ophthalmol 138:732–739. doi:10.1016/j.ajo.2004.06.088
Hikichi T, Fujio N, Akiba J, Azuma Y, Takahashi M, Yoshida A (1997) Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus. Ophthalmology 104:473–478
Hirano Y, Yasukawa T, Ogura Y (2010) Optical coherence tomography guided peeling of macular epiretinal membrane. Clin ophthalmol 5:27–29. doi:10.2147/OPTH.S16031
Inoue M, Morita S, Watanabe Y, Kaneko T, Yamane S, Kobayashi S, Arakawa A, Kadonosono K (2011) Preoperative inner segment/outer segment junction in spectral-domain optical coherence tomography as a prognostic factor in epiretinal membrane surgery. Retina 31:1366–1372. doi:10.1097/IAE.0b013e318203c156
Itakura H, Kishi S, Li D, Akiyama H (2013) Observation of posterior precortical vitreous pocket using swept-source optical coherence tomography. Invest Ophthalmol Vis Sci 54:3102–3107. doi:10.1167/iovs.13-11769
Jackson TL, Nicod E, Angelis A, Grimaccia F, Prevost AT, Simpson AR, Kanavos P (2013) Vitreous attachment in age-related macular degeneration, diabetic macular edema, and retinal vein occlusion: a systematic review and metaanalysis. Retina 33:1099–1108. doi:10.1097/IAE.0b013e31828991d6, Jetrea (2012) Iselin, NJ: ThromboGenics Inc
Johnson MW (2010) Posterior vitreous detachment: evolution and complications of its early stages. Am J Ophthalmol 149:371–382. doi:10.1016/j.ajo.2009.11.022
Kim JS, Chhablani J, Chan CK, Cheng L, Kozak I, Hartmann K, Freeman WR (2012) Retinal adherence and fibrillary surface changes correlate with surgical difficulty of epiretinal membrane removal. Am J Ophthalmol 153:692–697. doi:10.1016/j.ajo.2011.08.042
Kishi S, Demaria C, Shimizu K (1986) Vitreous cortex remnants at the fovea after spontaneous vitreous detachment. Int Ophthalmol 9:253–260
Koizumi H, Spaide RF, Fisher YL, Freund KB, Klancnik JM Jr, Yannuzzi LA (2008) Three-dimensional evaluation of vitreomacular traction and epiretinal membrane using spectral-domain optical coherence tomography. Am J Ophthalmol 145:509–517. doi:10.1016/j.ajo.2007.10.014
Libby RT, Champliaud MF, Claudepierre T, Xu Y, Gibbons EP, Koch M, Burgeson RE, Hunter DD, Brunken WJ (2000) Laminin expression in adult and developing retinae: evidence of two novel CNS laminins. J neurosci: the official journal of the Society for Neuroscience 20:6517–6528
Mayr-Sponer U, Waldstein SM, Kundi M, Ritter M, Golbaz I, Heiling U, Papp A, Simader C, Schmidt-Erfurth U (2013) Influence of the vitreomacular interface on outcomes of ranibizumab therapy in neovascular age-related macular degeneration. Ophthalmology 120:2620–2629. doi:10.1016/j.ophtha.2013.05.032
Mirshahi A, Hoehn F, Lorenz K, Hattenbach LO (2009) Incidence of posterior vitreous detachment after cataract surgery. J Cataract Refract Surg 35:987–991. doi:10.1016/j.jcrs.2009.02.016
Ophir A, Trevino A, Fatum S (2010) Extrafoveal vitreous traction associated with diabetic diffuse macular oedema. Eye 24:347–353. doi:10.1038/eye.2009.106
Puliafito CA, Hee MR, Lin CP, Reichel E, Schuman JS, Duker JS, Izatt JA, Swanson EA, Fujimoto JG (1995) Imaging of macular diseases with optical coherence tomography. Ophthalmology 102:217–229
Rispoli M, Le Rouic JF, Lesnoni G, Colecchio L, Catalano S, Lumbroso B (2012) Retinal surface en face optical coherence tomography: a new imaging approach in epiretinal membrane surgery. Retina 32:2070–2076. doi:10.1097/IAE.0b013e3182562076
Sebag J (1987) Age-related changes in human vitreous structure. Graefe’s Arch Clin Exp Ophthalmol = Albrecht von GraefesArchiv fur klinische und experimentelleOphthalmologie 225:89–93
Sebag J (2004) Anomalous posterior vitreous detachment: a unifying concept in vitreo-retinal disease. Graefe’s Arch Clin Exp Ophthalmol = Albrecht von GraefesArchiv fur klinische und experimentelleOphthalmologie 242:690–698. doi:10.1007/s00417-004-0980-1
Sebag J, Balazs EA (1989) Morphology and ultrastructure of human vitreous fibers. Invest Ophthalmol Vis Sci 30:1867–1871
Seidel G, Weger M, Stadlmuller L, Pichler T, Haas A (2013) Association of preoperative optical coherence tomography markers with residual inner limiting membrane in epiretinal membrane peeling. PLoS One 8:e66217. doi:10.1371/journal.pone.0066217
Sheard RM, Goodburn SF, Comer MB, Scott JD, Snead MP (2003) Posterior vitreous detachment after neodymium: YAG laser posterior capsulotomy. J Cataract Refract Surg 29:930–934
Singh RP, Li A, Bedi R, Srivastava S, Sears JE, Ehlers JP, Schachat AP, Kaiser PK (2014) Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndrome. Br J Ophthalmol 98:356–360. doi:10.1136/bjophthalmol-2013-304219
Snead DR, James S, Snead MP (2008) Pathological changes in the vitreoretinal junction 1: epiretinal membrane formation. Eye 22:1310–1317. doi:10.1038/eye.2008.36
Sonmez K, Capone A Jr, Trese MT, Williams GA (2008) Vitreomacular traction syndrome: impact of anatomical configuration on anatomical and visual outcomes. Retina 28:1207–1214. doi:10.1097/IAE.0b013e31817b6b0f
Spaide RF, Wong D, Fisher Y, Goldbaum M (2002) Correlation of vitreous attachment and foveal deformation in early macular hole states. Am J Ophthalmol 133:226–229
Stalmans P, Benz MS, Gandorfer A, Kampik A, Girach A, Pakola S, Haller JA, Group M-TS (2012) Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med 367:606–615. doi:10.1056/NEJMoa1110823
Stalmans P, Duker JS, Kaiser PK, Heier JS, Dugel PU, Gandorfer A, Sebag J, Haller JA (2013) Oct-based interpretation of the vitreomacular interface and indications for pharmacologic vitreolysis. Retina 33:2003–2011. doi:10.1097/IAE.0b013e3182993ef8
Steel DH, Lotery AJ (2013) Idiopathic vitreomacular traction and macular hole: a comprehensive review of pathophysiology, diagnosis, and treatment. Eye 27(Suppl 1):S1–S21. doi:10.1038/eye.2013.212
Suh MH, Seo JM, Park KH, Yu HG (2009) Associations between macular findings by optical coherence tomography and visual outcomes after epiretinal membrane removal. Am J Ophthalmol 147:473–480. doi:10.1016/j.ajo.2008.09.020
Tibbetts MD, Reichel E, Witkin AJ (2014) Vision loss after intravitreal ocriplasmin: correlation of spectral-domain optical coherence tomography and electroretinography. JAMA ophthalmol 132:487–490. doi:10.1001/jamaophthalmol.2013.8258
Uchino E, Uemura A, Ohba N (2001) Initial stages of posterior vitreous detachment in healthy eyes of older persons evaluated by optical coherence tomography. Arch Ophthalmol 119:1475–1479
Waldstein SM, Ritter M, Simader C, Mayr-Sponer U, Kundi M, Schmidt-Erfurth U (2014) Impact of vitreomacular adhesion on ranibizumab mono- and combination therapy for neovascular age-related macular degeneration. Am J Ophthalmol 158:328–336.e1. doi:10.1016/j.ajo.2014.04.02
Watanabe A, Arimoto S, Nishi O (2009) Correlation between metamorphopsia and epiretinal membrane optical coherence tomography findings. Ophthalmology 116:1788–1793. doi:10.1016/j.ophtha.2009.04.046
Wilkins JR, Puliafito CA, Hee MR, Duker JS, Reichel E, Coker JG, Schuman JS, Swanson EA, Fujimoto JG (1996) Characterization of epiretinal membranes using optical coherence tomography. Ophthalmology 103:2142–2151
Witkin AJ, Patron ME, Castro LC, Reichel E, Rogers AH, Baumal CR, Duker JS (2010) Anatomic and visual outcomes of vitrectomy for vitreomacular traction syndrome. Ophthalmic Surg Lasers Imaging : the official journal of the International Society for Imaging in the Eye 41:425–431. doi:10.3928/15428877-20100525-07
Worst JG (1977) Cisternal systems of the fully developed vitreous body in the young adult. Trans Ophthalmol Soc U K 97:550–554
Yamada N, Kishi S (2005) Tomographic features and surgical outcomes of vitreomacular traction syndrome. Am J Ophthalmol 139:112–117. doi:10.1016/j.ajo.2004.08.055
Yang HS, Hong JW, Kim YJ, Kim JG, Joe SG (2014) Characteristics of spontaneous idiopathic epiretinal membrane separation in spectral domain optical coherence tomography. Retina 34:20179–20187. doi:10.1097/IAE.0000000000000199
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer India
About this chapter
Cite this chapter
Tibbetts, M.D., Duker, J.S. (2017). Vitreomacular Traction and Epiretinal Membranes. In: Meyer, C., Saxena, S., Sadda, S. (eds) Spectral Domain Optical Coherence Tomography in Macular Diseases. Springer, New Delhi. https://doi.org/10.1007/978-81-322-3610-8_19
Download citation
DOI: https://doi.org/10.1007/978-81-322-3610-8_19
Published:
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-3608-5
Online ISBN: 978-81-322-3610-8
eBook Packages: MedicineMedicine (R0)